Biopharma and Innovative Drug Clinical Trial Seminar (Conducted in Chinese)
Date: September 17, 2021
Time: 2 PM – 5 PM
Location: Westin Hotel, Guangzhou China
China’s Center for Drug Evaluation (CDE) recently released a set of guiding principles calling for higher standards during drug development, and a greater focus on unmet patient needs in relation to domestic development of cancer drugs. Other recommendations included focusing on patients’ treatment experience and convenience in addition to treatment efficacy.
At this half-day seminar organized jointly by DXY Insight and Catalent, clinical trial industry leaders, sponsors and international experts will deliver presentations that focus on the challenges and pain points of running clinical trials, and strategies that can be employed to improve patient’s treatments and experience, which can in turn reduce waste and risk, and ultimately improve participation in clinical trials.
Daniel Gao, General Manager of Catalent Clinical Supply, Shanghai will provide the opening remarks for this seminar, and deliver a presentation entitled “Clinical Supply Risk Control: Strategies to Avoid Delays and Interruptions.”
To register for this event which will be conducted in Chinese, please scan the QR code below.